cadila healthcare ltd (CDH) Snapshot

Cadila Healthcare Ltd. announced its board of directors declared an interim dividend of INR 7.50 per equity share of INR 5 each for the year ended on March 31, 2013, at its meeting held on May 30, 2013. The board of directors has fixed June 12, 2013 as the record date for the determining the names of the shareholders entitled to receive the dividend. The dividend will be payable on or after June 17, 2013.

Cadila Healthcare Limited reported audited consolidated and standalone earnings results for the fourth quarter and year ended March 31, 2013. For the quarter, on a consolidated basis, the company reported total income from operations of INR 16,119.0 million against INR 13,980.0 million for the same period last year. Profit from operations before other income, finance costs and exceptional items was INR 2,398.3 million compared to INR 2,437.3 million a year ago. Profit from ordinary activities before tax was INR 2,170.0 million against INR 2,237.7 million for the same period last year. Net profit for the period was INR 2,753.0 million or INR 12.82 per basic and diluted share against INR 1,801.4 million or INR 8.35 per basic and diluted share for the same period last year. For the year, on a consolidated basis, the company reported total income from operations of INR 63,580.7 million against INR 52,633.1 million for the same period last year. Profit from operations before other income, finance costs and exceptional items was INR 9,428.5 million compared to INR 9,259.8 million a year ago. Profit from ordinary activities before tax was INR 8,112.2 million against INR 7,942.3 million for the same period last year. Net profit for the period was INR 6,917.3 million or INR 32.01 per basic and diluted share against INR 6,811.9 million or INR 31.87 per basic and diluted share for the same period last year. Earnings before interest, depreciation and tax, excluding the impact of onetime loss in income received in the previous year, was up by 9% to INR 11,255 million from INR 10,325 million last year. Net profit, excluding onetime income, was up by 7% to INR 6,551 million from INR 6,116 million last year. The consolidated debt, on a gross level, stood at INR 29,219 million. The consolidated capex for the year was INR 6,881 million. Capex on R&D included in this was INR 495 million. For the quarter, on a standalone basis, the company reported total income from operations of INR 9,539.6 million against INR 7,837.8 million for the same period last year. Profit from operations before other income, finance costs and exceptional items was INR 2,096.8 million compared to INR 1,527.8 million a year ago. Profit from ordinary activities before tax was INR 2,023.2 million against INR 1,475.1 million for the same period last year. Net profit for the period was INR 2,025.3 million or INR 9.89 per basic and diluted share against INR 1,394.0 million or INR 6.81 per basic and diluted share for the same period last year. For the year, on a standalone basis, the company reported total income from operations of INR 33,642.2 million against INR 31,507.8 million for the same period last year. Profit from operations before other income, finance costs and exceptional items was INR 5,029.9 million compared to INR 5,595.5 million a year ago. Profit from ordinary activities before tax was INR 4,685.3 million against INR 6,704.3 million for the same period last year. Net profit for the period was INR 4,666.4 million or INR 22.79 per basic and diluted share against INR 6,575.2 million or INR 32.11 per basic and diluted share for the same period last year. The company expects tax rate is to be around 15% for the next year. The company expects capex is to be INR 6,000 million in the fiscal 2014.

Cadila Healthcare Limited - Special Call